Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics

被引:102
作者
Ellingson, Benjamin M. [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Comp Vis & Imaging Biomarkers CVIB, UCLA Brain Tumor Imaging Lab BTIL, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Neurooncol Program, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Res Inst BRI, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomed Phys, Los Angeles, CA 90024 USA
[6] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA
关键词
Radiogenomics; Imaging genomics; GBM; Imaging phenotypes; CEREBRAL BLOOD-VOLUME; MGMT PROMOTER METHYLATION; DIFFUSION-WEIGHTED MRI; CONTRAST-ENHANCED MR; BRAIN-TUMORS; GENE-EXPRESSION; STEM-CELLS; ADJUVANT TEMOZOLOMIDE; GRADE ASTROCYTOMAS; SURVIVAL;
D O I
10.1007/s11910-014-0506-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Radiogenomics is a provocative new area of research based on decades of previous work examining the association between radiological and histological features. Many generalized associations have been established linking anatomical imaging traits with underlying histopathology, including associations between contrast-enhancing tumor and vascular and tumor cell proliferation, hypointensity on pre-contrast T1-weighted images and necrotic tissue, and associations between hyperintensity on T2-weighted images and edema or nonenhancing tumor. Additionally, tumor location, tumor size, composition, and descriptive features tend to show significant associations with molecular and genomic factors, likely related to the cell of origin and growth characteristics. Additionally, physiologic MRI techniques also show interesting correlations with underlying histology and genomic programs, including associations with gene expression signatures and histological subtypes. Future studies extending beyond simple radiology-histology associations are warranted in order to establish radiogenomic analyses as tools for prospectively identifying patient subtypes that may benefit from specific therapies.
引用
收藏
页数:12
相关论文
共 102 条
[81]   CONTRAST AGENTS AND CEREBRAL HEMODYNAMICS [J].
ROSEN, BR ;
BELLIVEAU, JW ;
BUCHBINDER, BR ;
MCKINSTRY, RC ;
PORKKA, LM ;
KENNEDY, DN ;
NEUDER, MS ;
FISEL, CR ;
ARONEN, HJ ;
KWONG, KK ;
WEISSKOFF, RM ;
COHEN, MS ;
BRADY, TJ .
MAGNETIC RESONANCE IN MEDICINE, 1991, 19 (02) :285-292
[82]   PERFUSION IMAGING WITH NMR CONTRAST AGENTS [J].
ROSEN, BR ;
BELLIVEAU, JW ;
VEVEA, JM ;
BRADY, TJ .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (02) :249-265
[83]   Glioma vascularity correlates with reduced patient survival and increased malignancy [J].
Russell, Stephen M. ;
Elliott, Robert ;
Forshaw, David ;
Golfinos, John G. ;
Nelson, Peter K. ;
Kelly, Patrick J. .
SURGICAL NEUROLOGY, 2009, 72 (03) :242-246
[84]   Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging [J].
Rutman, Aaron M. ;
Kuo, Michael D. .
EUROPEAN JOURNAL OF RADIOLOGY, 2009, 70 (02) :232-241
[85]   Mechanisms of disease: Neural stem cells and the origin of gliomas [J].
Sanai, N ;
Alvarez-Buylla, A ;
Berger, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (08) :811-822
[86]   INFLUENCE OF LOCATION AND EXTENT OF SURGICAL RESECTION ON SURVIVAL OF PATIENTS WITH GLIOBLASTOMA-MULTIFORME - RESULTS OF 3 CONSECUTIVE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) CLINICAL-TRIALS [J].
SIMPSON, JR ;
HORTON, J ;
SCOTT, C ;
CURRAN, WJ ;
RUBIN, P ;
FISCHBACH, J ;
ISAACSON, S ;
ROTMAN, M ;
ASBELL, SO ;
NELSON, JS ;
WEINSTEIN, AS ;
NELSON, DF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (02) :239-244
[87]  
Stewart G N, 1897, J Physiol, V22, P159
[88]   Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J].
Stupp, R ;
Mason, WP ;
van den Bent, MJ ;
Weller, M ;
Fisher, B ;
Taphoorn, MJB ;
Belanger, K ;
Brandes, AA ;
Marosi, C ;
Bogdahn, U ;
Curschmann, J ;
Janzer, RC ;
Ludwin, SK ;
Gorlia, T ;
Allgeier, A ;
Lacombe, D ;
Cairncross, JG ;
Eisenhauer, E ;
Mirimanoff, RO ;
Van Den Weyngaert, D ;
Kaendler, S ;
Krauseneck, P ;
Vinolas, N ;
Villa, S ;
Wurm, RE ;
Maillot, MHB ;
Spagnolli, F ;
Kantor, G ;
Malhaire, JP ;
Renard, L ;
De Witte, O ;
Scandolaro, L ;
Vecht, CJ ;
Maingon, P ;
Lutterbach, J ;
Kobierska, A ;
Bolla, M ;
Souchon, R ;
Mitine, C ;
Tzuk-Shina, T ;
Kuten, A ;
Haferkamp, G ;
de Greve, J ;
Priou, F ;
Menten, J ;
Rutten, I ;
Clavere, P ;
Malmstrom, A ;
Jancar, B ;
Newlands, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :987-996
[89]   Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial [J].
Stupp, Roger ;
Hegi, Monika E. ;
Mason, Warren P. ;
van den Bent, Martin J. ;
Taphoorn, Martin J. B. ;
Janzer, Robert C. ;
Ludwin, Samuel K. ;
Allgeier, Anouk ;
Fisher, Barbara ;
Belanger, Karl ;
Hau, Peter ;
Brandes, Alba A. ;
Gijtenbeek, Johanna ;
Marosi, Christine ;
Vecht, Charles J. ;
Mokhtari, Karima ;
Wesseling, Pieter ;
Villa, Salvador ;
Eisenhauer, Elizabeth ;
Gorlia, Thierry ;
Weller, Michael ;
Lacombe, Denis ;
Cairncross, J. Gregory ;
Mirimanoff, Rene-Olivier .
LANCET ONCOLOGY, 2009, 10 (05) :459-466
[90]  
Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO